NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Mahindra Lifespace Developers Reports Record Quarterly Residential Sales

Mahindra Lifespace Developers (MAHLIFE) has achieved record quarterly residential sales, driven by strong launches. According to a recent report by Choice Institutional Equities, MAHLIFE's pre-sales and collections rose significantly, with a year-over-year (YoY) growth of 54.8% and 36.3%, respectively. The Average Selling Price (ASP) also grew by a substantial 35.1% YoY, backed by pre-sales from new launches.

The company's recent launch of Mahindra Blossom in Bengaluru was a notable success, with 60% sales achieved within a week of launch. This strong performance is a testament to the company's ability to execute its business strategy effectively.

Maintaining a 'BUY' Rating

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Choice Institutional Equities maintains its 'BUY' rating on MAHLIFE with a target price (TP) of INR 500. The report takes into account the company's Residential Business, Industrial Cities and Integrated Cities (IC&IC), and Operations & Maintenance (O&M) segments, as well as its historical land bank.

SegmentQoQ GrowthYoY Growth
Pre-sales54.8%
Collections36.3%
Average Selling Price35.1%

Note: QoQ growth refers to quarter-over-quarter growth, while YoY growth refers to year-over-year growth.

Investor Takeaway

Investors should consider buying Mahindra Lifespace Developers with a target price of Rs 500.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.